Price
Frequently asked questions
What is DermTech's market capitalization?
The market capitalization of DermTech is $30.00. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is the Earnings Per Share (EPS) for DermTech?
DermTech's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$2.685. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for DermTech's stock?
Currently, 1 analysts cover DermTech's stock, with a consensus target price of $1.50. Analyst ratings provide insights into the stock's expected performance.
What is DermTech's revenue over the trailing twelve months?
Over the trailing twelve months, DermTech reported a revenue of $15.66M.
What is the EBITDA for DermTech?
DermTech's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$90.37M. EBITDA measures the company's overall financial performance.
What is the free cash flow of DermTech?
DermTech has a free cash flow of -$72.22M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
What is the 5-year beta of DermTech's stock?
The 5-year beta for DermTech is 2.21. A beta value indicates the stock's volatility relative to the market; a beta greater than 1 means higher volatility.
How many employees does DermTech have, and what sector and industry does it belong to?
DermTech employs approximately 206 people. It operates in the Financials sector, specifically within the Misc. Financial Services industry.
What is the free float of DermTech's shares?
The free float of DermTech is 34.05M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
Market Cap
$30.005Y beta
2.21EPS (TTM)
-$2.685Free Float
34.05MRevenue (TTM)
$15.66MEBITDA (TTM)
-$90.37MFree Cashflow (TTM)
-$72.22MPricing
52W span
$0.000001$1.99
Analyst Ratings
The price target is $1.50 and the stock is covered by 1 analysts.
Buy
0
Hold
1
Sell
0
Information
DermTech, Inc. has filed a voluntary petition under Chapter 11 of the U.S. Bankruptcy Code and is winding down its business. The Company has no business operations.
206
Misc. Financial Services
Financials
Identifier
ISIN
US24984K1051
Primary Ticker
DMTK